{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:52:15Z","timestamp":1773964335558,"version":"3.50.1"},"reference-count":88,"publisher":"Japan Atherosclerosis Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT"],"published-print":{"date-parts":[[2012]]},"DOI":"10.5551\/jat.10454","type":"journal-article","created":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T05:32:49Z","timestamp":1323840769000},"page":"299-315","source":"Crossref","is-referenced-by-count":69,"title":["Chronic Kidney Disease, Dyslipidemia, and Atherosclerosis"],"prefix":"10.5551","volume":"19","author":[{"given":"Tetsuo","family":"Shoji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genshi","family":"Egusa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshimitsu","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kashihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohji","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3489","reference":[{"key":"1","unstructured":"1) Japanese Society for Dialysis Therapy: An overview of regular dialysis treatment in Japan as of Dec. 31, 2009. Tokyo2010"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1998.v32.pm9820470"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197403282901301"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000031732.78052.81"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(02)02663-3"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000095676.90936.80"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) European best practice guidelines for haemodialysis (part I). Section VII. Vascular disease and risk factors. Nephrol Dial Transplant, 2002; 17 (Suppl 7): 88-109","DOI":"10.1093\/ndt\/17.suppl_7.88"},{"key":"8","unstructured":"8) K\/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis, 2003; 41: I-IV, S1-91"},{"key":"9","unstructured":"9) Clinical Practice Guidebook for Diagnosis and Treatment of Chronic Kidney Disease 2007. Tokyo: Tokyo Igaku Sha; 2007 (in Japanese)"},{"key":"10","unstructured":"10) Japanese Society of Nephrology: Evidence-based Clinical Practice Guidelines for the treatment of CDK. Tokyo: Tokyo Igakusha; 2009 (in Japanese)"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.5551\/jat.14.45"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.32799"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00365.x"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.483"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(84)90763-4"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE: Microalbuminuria as predictor of increased mortality in elderly people. Bmj, 1990; 300: 297-300","DOI":"10.1136\/bmj.300.6720.297"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P: Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med, 2003; 139: 901-906","DOI":"10.7326\/0003-4819-139-11-200312020-00008"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000133312.96477.48"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH: Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med, 2004; 164: 659-663","DOI":"10.1001\/archinte.164.6.659"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) K\/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis, 2004; 43: S1-290","DOI":"10.1053\/j.ajkd.2004.03.003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Brugts JJ, Knetsch AM, Mattace-Raso FU, Hofman A, Witteman JC: Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study. Arch Intern Med, 2005; 165: 2659-2665","DOI":"10.1001\/archinte.165.22.2659"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kottgen A, Russell SD, Loehr LR, Crainiceanu CM, Rosamond WD, Chang PP, Chambless LE, Coresh J: Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. J Am Soc Nephrol, 2007; 18: 1307-1315","DOI":"10.1681\/ASN.2006101159"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Weiner DE, Tighiouart H, Levey AS, Elsayed E, Griffith JL, Salem DN, Sarnak MJ: Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. J Am Soc Nephrol, 2007; 18: 960-966","DOI":"10.1681\/ASN.2006080858"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, Patel A, Cass A, Neal B, Poulter N, Mogensen CE, Cooper M, Marre M, Williams B, Hamet P, Mancia G, Woodward M, Macmahon S, Chalmers J: Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes. J Am Soc Nephrol, 2009","DOI":"10.1681\/ASN.2008121270"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00397.x"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.109.550707"},{"key":"28","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.792903"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1253\/circj.70.954"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Irie F, Iso H, Sairenchi T, Fukasawa N, Yamagishi K, Ikehara S, Kanashiki M, Saito Y, Ota H, Nose T: The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int, 2006; 69: 12641271","DOI":"10.1038\/sj.ki.5000284"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Hatta T, Nishimura S, Nishimura T: Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging, 2009; 36: 18351841","DOI":"10.1007\/s00259-009-1165-2"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-2370"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60674-5"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32832c6968"},{"key":"35","unstructured":"35) Nishizawa Y, Shoji T: Does dialysis treatment promote atherosclerosis? . Jap J Clin Dial (Rinsho Toseki), 1996; 12: 1133-1144 (in Japanese)"},{"key":"36","unstructured":"36) Japanese Society for Dialysis Therapy: An overview of regular dialysis treatment in Japan as of Dec.31, 2005 (CDROM version). Tokyo: Japanese Society for Dialysis Therapy; 2006 (in Japanese)"},{"key":"37","unstructured":"37) Ministry of Health, Labour and Welfare. Japanese Population Dynamics in 2005. http:\/\/www.mhlw.go.jp\/toukei\/ saikin\/hw\/jinkou\/suikei05\/. Accessed May 3, 2011(in Japanese): Statistical Bureau, Ministry of Internal Affairs and Communications, Japan. The national census as of Oct 1, 2005. http:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/ jinkou\/suikei05\/index.html. Accessed May 3, 2011 (in Japanese)"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Kronenberg F: Dyslipidemia and nephrotic syndrome: recent advances. J Ren Nutr, 2005; 15: 195-203","DOI":"10.1053\/j.jrn.2004.10.003"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(76)90022-6"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Wanner C, Quaschning T: Dyslipidemia and renal disease: pathogenesis and clinical consequences. Curr Opin Nephrol Hypertens, 2001; 10: 195-201","DOI":"10.1097\/00041552-200103000-00007"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Ikewaki K, Schaefer JR, Frischmann ME, Okubo K, Hosoya T, Mochizuki S, Dieplinger B, Trenkwalder E, Schweer H, Kronenberg F, Koenig P, Dieplinger H: Delayed in vivo catabolism of intermediate-density lipoprotein and low-density lipoprotein in hemodialysis patients as potential cause of premature atherosclerosis. Arterioscler Thromb Vasc Biol, 2005; 25: 2615-2622","DOI":"10.1161\/01.ATV.0000188555.60475.c2"},{"key":"42","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1992.238"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(91)90120-L"},{"key":"44","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27393"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Oi K, Hirano T, Sakai S, Kawaguchi Y, Hosoya T: Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients. Kidney Int Suppl, 1999; 71: S227-228","DOI":"10.1046\/j.1523-1755.1999.07159.x"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Shoji T, Emoto M, Kawagishi T, Kimoto E, Yamada A, Tabata T, Ishimura E, Inaba M, Okuno Y, Nishizawa Y: Atherogenic lipoprotein changes in diabetic nephropathy. Atherosclerosis, 2001; 156: 425-433","DOI":"10.1016\/S0021-9150(00)00673-0"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.5551\/jat.9.305"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.4.718"},{"key":"49","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004090765"},{"key":"50","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2006.03.008"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.356"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00372.x"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Shoji T, Nishizawa Y, Kawagishi T, Kawasaki K, Taniwaki H, Tabata T, Inoue T, Morii H: Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients. J Am Soc Nephrol, 1998; 9: 1277-1284","DOI":"10.1681\/ASN.V971277"},{"key":"54","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00468.x"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Rigatto C, Levin A, House AA, Barrett B, Carlisle E, Fine A: Atheroma progression in chronic kidney disease. Clin J Am Soc Nephrol, 2009; 4: 291-298","DOI":"10.2215\/CJN.01840408"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Fukumoto M, Shoji T, Emoto M, Kawagishi T, Okuno Y, Nishizawa Y: Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population. Arterioscler Thromb Vasc Biol, 2000; 20: 703-707","DOI":"10.1161\/01.ATV.20.3.703"},{"key":"57","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005101038"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis, 1990; 15: 458-482","DOI":"10.1016\/S0272-6386(12)70364-5"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C: Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study. Nephron, 1982; 31: 103-110","DOI":"10.1159\/000182627"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD: Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int, 2003; 63: 793808","DOI":"10.1046\/j.1523-1755.2003.00803.x"},{"key":"61","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2001.27380"},{"key":"62","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.44.179"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09961110"},{"key":"64","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.7.953"},{"key":"65","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)11798-3"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12948-0"},{"key":"67","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000143892.84582.60"},{"key":"68","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2006.06.003"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2009.03.031"},{"key":"70","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.03.022"},{"key":"71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043545"},{"key":"72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810177"},{"key":"73","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09121010"},{"key":"74","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60739-3"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, Buring JE, Gaziano JM: Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol, 2003; 14: 2084-2091","DOI":"10.1681\/ASN.V1482084"},{"key":"76","doi-asserted-by":"publisher","DOI":"10.1159\/000186665"},{"key":"77","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.5.798"},{"key":"78","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006010012"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Nakamura T, Kawagoe Y, Ogawa H, Ueda Y, Hara M, Shimada N, Ebihara I, Koide H: Effect of low-density lipoprotein apheresis on urinary protein and podocyte excretion in patients with nephrotic syndrome due to diabetic nephropathy. Am J Kidney Dis, 2005; 45: 48-53","DOI":"10.1053\/j.ajkd.2004.09.013"},{"key":"80","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2003.012989"},{"key":"81","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04371206"},{"key":"82","doi-asserted-by":"publisher","DOI":"10.5551\/jat.3764"},{"key":"83","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2005.05.012"},{"key":"84","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67667-2"},{"key":"85","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.19.2486"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86) Japanese Society for Dialysis Therapy: Clinical Guidelines for the Evaluation and the Treatment of Cardiovascular Complications in Hemodialysis Patients. J Jap Soc Dial Ther, 2011; 44: 337-425","DOI":"10.4009\/jsdt.44.337"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chapman MJ, Durrington P, Erdine S, Halcox J, Hobbs R, Kjekshus J, Filardi PP, Riccardi G, Storey RF, Wood D, Bax J, Vahanian A, Auricchio A, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Filippatos G, Funck-Brentano C, Hasdai D, Hoes A, Kearney P, Knuuti J, Kolh P, McDonagh T, Moulin C, Poldermans D, Popescu BA, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vardas P, Widimsky P, Windecker S, Berkenboom G, De Graaf J, Descamps O, Gotcheva N, Griffith K, Guida GF, Gulec S, Henkin Y, Huber K, Kesaniemi YA, Lekakis J, Manolis AJ, Marques-Vidal P, Masana L, McMurray J, Mendes M, Pagava Z, Pedersen T, Prescott E, Rato Q, Rosano G, Sans S, Stalenhoef A, Tokgozoglu L, Viigimaa M, Wittekoek ME, Zamorano JL: ESC\/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Eur Heart J, 2011; 32: 1769-1818","DOI":"10.1093\/eurheartj\/ehr158"},{"key":"88","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2009.09.020"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T18:40:32Z","timestamp":1742064032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/19\/4\/19_10454\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.10454","relation":{},"ISSN":["1880-3873","1340-3478"],"issn-type":[{"value":"1880-3873","type":"electronic"},{"value":"1340-3478","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}